Systemic sclerosis - diffuse cutaneous

Clinical trials for Systemic sclerosis - diffuse cutaneous explained in plain language.

Never miss a new study

Get alerted when new Systemic sclerosis - diffuse cutaneous trials appear

Sign up with your email to follow new studies for Systemic sclerosis - diffuse cutaneous, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

Experimental CAR-T therapy takes aim at Hard-to-Treat scleroderma

Disease control Stopped early

This early-phase trial is testing a new treatment called KYV-101 for people with systemic sclerosis, a disease where the immune system attacks the body, causing skin and organ damage. The therapy uses a patient's own modified immune cells to target and destroy certain B cells tha…

Matched conditions: SYSTEMIC SCLEROSIS - DIFFUSE CUTANEOUS

Phase 1/2 • Sponsor: Kyverna Therapeutics • Aim: Disease control

Last updated Sep 02, 2026 00:00 UTC

Systemic sclerosis - diffuse cutaneous

Get alerted when new Systemic sclerosis - diffuse cutaneous trials appear

Experimental CAR-T therapy takes aim at Hard-to-Treat scleroderma